Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections (Q37998530)

26 August 2017

title

Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections (English)

1 reference

Magnus von Knebel Doeberitz

26 August 2017

0 references

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author

series ordinal

object named as

Magnus von Knebel Doeberitz

1 reference

26 August 2017

Miriam Reuschenbach

1 reference

26 August 2017

Dietmar Schmidt

series ordinal

1 reference

26 August 2017

Christine Bergeron

series ordinal

1 reference

26 August 2017

publication date

1 April 2012

1 reference

Expert Review of Proteomics

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

149-163

1 reference

How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case

26 August 2017

cites work

1 reference

Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.

21 January 2018

1 reference

Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.

21 January 2018

1 reference

Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells

21 January 2018

1 reference

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 January 2018

1 reference

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

21 January 2018

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature

21 January 2018

1 reference

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

Human papillomavirus and cervical cancer

21 January 2018

1 reference

Natural history of cervicovaginal papillomavirus infection in young women

21 January 2018

1 reference

Epidemiology and pathology of HPV disease in males

21 January 2018

1 reference

Persistence of human papillomavirus infection: keys to malignant progression

21 January 2018

1 reference

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

The Evaluation of p16ink4a Immunoexpression/Immunostaining and Human Papillomavirus DNA Test in Cervical Liquid-Based Cytological Samples

21 January 2018

1 reference

Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2.

21 January 2018

1 reference

Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections

21 January 2018

1 reference

Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses

21 January 2018

1 reference

Genomic instability and cancer: Lessons learned from human papillomaviruses

21 January 2018

1 reference

Using biomarkers as objective standards in the diagnosis of cervical biopsies

21 January 2018

1 reference

Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.

21 January 2018

1 reference

p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.

21 January 2018

1 reference

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

The significance of unstable chromosomes in colorectal cancer.

21 January 2018

1 reference

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

21 January 2018

1 reference

Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?

21 January 2018

1 reference

Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.

21 January 2018

1 reference

DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri

21 January 2018

1 reference

HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review

21 January 2018

1 reference

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

21 January 2018

1 reference

A magnetic immunochromatographic strip test for detection of human papillomavirus 16 E6.

21 January 2018

1 reference

High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma

21 January 2018

1 reference

Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines

21 January 2018

1 reference

Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.

21 January 2018

1 reference

Molecular profiling of cervical neoplasia.

21 January 2018

1 reference

Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology

21 January 2018

1 reference

A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia

21 January 2018

1 reference

Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia

21 January 2018

1 reference

MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India

21 January 2018

1 reference

Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?

21 January 2018

1 reference

Ink4a/Arf links senescence and aging

21 January 2018

1 reference

Cellular senescence in cancer and aging

21 January 2018

1 reference

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

The tumor suppressor protein p16INK4a.

21 January 2018

1 reference

The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments

21 January 2018

1 reference

INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.

21 January 2018

1 reference

Reversal of human cellular senescence: roles of the p53 and p16 pathways

21 January 2018

1 reference

Chromatin modifications and their function

21 January 2018

1 reference

The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence

21 January 2018

1 reference

Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS

21 January 2018

1 reference

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

21 January 2018

1 reference

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation

21 January 2018

1 reference

Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions

21 January 2018

1 reference

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

21 January 2018

1 reference

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

21 January 2018

1 reference

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

21 January 2018

1 reference

Consistency in the histological diagnosis of epithelial abnormalities of the cervix uteri

21 January 2018

1 reference

Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia

21 January 2018

1 reference

Efforts to improve interobserver agreement in histopathological grading

21 January 2018

1 reference

Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia

21 January 2018

1 reference

Observer variability in histopathological reporting of cervical biopsy specimens

21 January 2018

1 reference

Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia.

21 January 2018

1 reference

p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions

21 January 2018

1 reference

Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.

21 January 2018

1 reference

Diagnosing cervical biopsies in adolescents: the use of p16 immunohistochemistry to improve reliability and reproducibility.

21 January 2018

1 reference

Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki‐67 in epithelial cells

21 January 2018

1 reference

Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests

21 January 2018

1 reference

Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens

21 January 2018

1 reference

p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear

21 January 2018

1 reference

p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

21 January 2018

1 reference

Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.

21 January 2018

1 reference

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results

21 January 2018

1 reference

Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.

21 January 2018

1 reference

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

21 January 2018

1 reference

P16INK4a as an adjunct marker in liquid-based cervical cytology.

21 January 2018

1 reference

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology

21 January 2018

1 reference

BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening

21 January 2018

1 reference

Diagnosing Cervical Cancer and High-Grade Precursors by HPV16 Transcription Patterns

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EPR.12.13

1 reference

26 August 2017

1 reference